Effect of desirable fasting triglycerides on the postprandial response to dietary fat

被引:11
作者
Miller, M
Zhan, M
Georgopoulos, A
机构
[1] Univ Maryland, Vet Affairs Med Ctr, Div Cardiol, Dept Med, Baltimore, MD 21201 USA
[2] Univ Minnesota, Dept Med, Vet Affairs Med Ctr, Minneapolis, MN 55455 USA
关键词
National Cholesterol Education Program; postprandial; triglycerides; lipoproteins; atherothrombosis;
D O I
10.2310/6650.2003.33544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The National Cholesterol Education Program (NCEP) recently revised the "desirable" fasting triglyceride (TG) to < 150 mg/dL, and levels exceeding 200 mg/dL are defined as "high." Methods: To evaluate the postprandial response to dietary fat, 50 studies were conducted in nonobese, normocholesterolemic subjects. Following an overnight fast, subjects consumed an oral fat load (70 g/M-2), and postprandial triglyceride (ppTG) measurements were assessed at 2, 4, 6, and 8 hours. Subjects were divided by fasting TG cutpoints of 100 and 150 mg/dL. Results: The prevalence of ppTG samples exceeding 200 mg/dL was significantly lower with fasting TG < 100 mg/dL (n= 116) compared with TG 100 to 150 mg/dL (n= 56) (8% versus 25%; p=.004, chi-square analysis). In addition, fasting TG < 100 mg/dL (n = 29) was associated with a reduced mean 4-hour peak ppTG level compared with fasting TG > 100 mg/dL (n = 21 (125 mg/dL versus 249.8 mg/dL; p < .0001). Multiple linear regression analysis identified fasting TG as the most important determinant of the postprandial response after adjustment for other covariates (p =.0005). Conclusions: Because ppTG-rich lipoproteins contribute to coronary heart disease risk, fasting TG < 100 mg/dL may be a more desirable cutpoint than fasting TG < 150 mg/dL in coronary heart disease risk factor assessment.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 40 条
[1]   Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) :1179-1184
[2]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[3]  
Bosner MS, 1999, J LIPID RES, V40, P302
[4]   A macrophage receptor for apolipoprotein B48: Cloning, expression, and atherosclerosis [J].
Brown, ML ;
Ramprasad, MP ;
Umeda, PK ;
Tanaka, A ;
Kobayashi, Y ;
Watanabe, T ;
Shimoyamada, H ;
Kuo, WL ;
Li, R ;
Song, RL ;
Bradley, WA ;
Gianturco, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7488-7493
[5]  
Campos H, 2001, J LIPID RES, V42, P1239
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]  
COHN JS, 1988, J LIPID RES, V29, P469
[8]  
Dichtl W, 2000, THROMB HAEMOSTASIS, V84, P706
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]   HYPERAPOBETALIPOPROTEINEMIA - PLASMA-LIPOPROTEIN RESPONSES TO ORAL FAT LOAD [J].
GENEST, J ;
SNIDERMAN, A ;
CIANFLONE, K ;
TENG, BB ;
WACHOLDER, S ;
MARCEL, Y ;
KWITEROVICH, P .
ARTERIOSCLEROSIS, 1986, 6 (03) :297-304